StockData
GSK plc logo

GSK plc (GSK) stock

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$48.58−0.66 (-1.34%)

Close on Nov 18, 2026Market cap $104.82BP/E 13.2Yield –

GSK pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

GSK's pe ratio was 13.6× on Nov 11, 2026, against 29.1× a year earlier. Over the last 5 years it ranged from 3.7× to 35.3×, with a median of 13.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202613.6×−15.7
2025Dec 31, 202529.3×+18.1
2024Dec 31, 202411.3×+7.3
2023Dec 29, 20234.0×−9.5
2022Dec 30, 202213.4×−0.6
2021Dec 31, 202114.0×−0.2
2020Dec 31, 202014.3×−9.6
2019Dec 31, 201923.8×−23.5
2018Dec 31, 201847.4×−21.8
2017Dec 29, 201769.1×+60.2
2016Dec 30, 20168.9×–

More GSK figures

See a number that looks wrong?